Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Companies Leading The Industry Pack - CRWE, FDO, PSE, ARIA



Crown Equity Holdings Inc. (OTCBB:CRWE) announces that its sales this year have already surpassed $1,000,000. This compares to $232,510 for the three quarters ending September 30, 2009 and $ 659,907 total sales for the year 2009.

"Based on our sales to date, we had more than 4 times the sales for the same period last year and are 34% ahead of last year's total sales," commented Kenneth Bosket, President and CEO of Crown Equity Holdings Inc. "Our growth in sales along with our investments in infrastructure and people give the company a basis for supporting future growth of the magnitude we have seen so far this year," stated Bosket.

Crown Equity Holdings Inc. has expanded its internet footprint internationally to include the following 19 countries: Argentina, Australia, Brazil, Canada, China, France, Germany, Hong Kong, India, Ireland, Italy, Japan, Korea, Mexico, New Zealand, Singapore, Spain, Taiwan and the UK.

Crown Equity Holdings Inc. is a consulting organization which provides and assists small business owners with the knowledge required in taking their company public, and has re-focused its primary vision with its aligned group of independent website divisions to providing media advertising services, as a worldwide online media advertising publisher, dedicated to the distribution of quality branding information, as well as search engine optimization for its clients.


Family Dollar Stores, Inc. (NYSE:FDO) recently reported that the Company’s Board of Directors has declared a regular quarterly cash dividend on the Company’s common stock of $0.155 per share, payable Friday, January 14, 2011, to shareholders of record at the close of business on Wednesday, December 15, 2010.


Pioneer Southwest Energy Partners L.P. (NYSE:PSE) recently announced a cash distribution of $0.50 per unit on PSE's outstanding common units for the quarter ended September 30, 2010.

The distribution is payable November 12, 2010, to unitholders of record at the close of business on November 4, 2010.


ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) recently reported interim results of a randomized, open-label, active-control multicenter Phase 2 study of oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic or recurrent endometrial cancer.

Based on this interim analysis, the study demonstrated a statistically significant improvement in the primary endpoint of median progression-free survival (NYSE:PFS) in patients receiving single-agent ridaforolimus compared to patients receiving standard-of-care treatment.

Ridaforolimus is currently being developed by Merck in multiple cancer indications under an exclusive license and collaboration agreement with ARIAD.


Signup for FREE Daily Stock Alerts From


Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.